Numerous evidence implicates that upregulation of KGA, especially GAC (jointly referred to as GLS henceforth), plays a critical role in tumor proliferation throughout various types of cancers, such as glioma, lymphoma, non-small cell lung cancer, prostate cancer, and triple-negative breast cancer [54,55,56,57]. The gene discussed is GLS; the disease is non-small cell lung carcinoma.